| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6050805 | Archives of Oral Biology | 2016 | 8 Pages |
Abstract
Sinuleptolide can induce an antiproliferation of oral cancer Ca9-22 cells involving apoptosis, oxidative stress and DNA damage, suggesting that sinuleptolide represents a potential chemotherapeutic drug for oral cancer treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Yung-Ting Chang, Chiung-Yao Huang, Kun-Tzu Li, Ruei-Nian Li, Chih-Chuang Liaw, Shih-Hsiung Wu, Jing-Ru Liu, Jyh-Horng Sheu, Hsueh-Wei Chang,